Genentech

Roche will leverage PicnicHealth's real-world datasets for Alzheimer’s Disease, Alzheimer’s Disease-related dementia and myasthenia gravis.

The original focus will be on multiple sclerosis but will extend to include Huntington's disease and hemophilia. 

Mail-order personal genetics service and research company 23andMe has completed a $115 million in a round led by Fidelity Management and Research Company with participation from  Casdin Capital, WuXi Healthcare Ventures, and Xfund, as well as existing investors Illumina, New Enterprise Associates, MPM Capital, and Google Ventures.

Propeller Health is working with Boehringer Ingelheim.

According to an SEC filing, mail-order personal genome service and research company 23andMe has raised $79 million, in a round the company hopes will top out at $150 million.

David Ebersman Lyra Health, a startup that launched last week, will focus on addressing the gaps in the healthcare system surrounding behavioral health conditions like anxiety and depression.

Cambridge-based online patient community business PatientsLikeMe is teaming up with Boston-area health system Partners HealthCare to provide information and insights from PLM's platform to Partners' patients.

Roche subsidiary Genentech is no stranger to online patient communities -- the pharma company signed a five-year data access deal with online patient community company PatientsLikeMe in April.